Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2662929015 | Recombinant hepatitis B virus surface antigen 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms injection solution 0.5mL prefilled syringe (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2674862010 | Recombinant hepatitis B virus surface antigen 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms injection solution 0.5mL prefilled syringe | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3249371000052112 | rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Is a | vaccin mot difteri, stelkramp och kikhosta samt rekombinant vaccin mot hepatit B-virus | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | rekombinant vaccin mot hepatit B-virus | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | Diphtheria vaccine | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | kikhostevaccin | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | Tetanus toxoid | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has manufactured dose form | för injektion | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | difteritoxoid | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | stelkrampsvaccin | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | difterivaccin | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has manufactured dose form | Solution for injection | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | kikhostevaccin | false | Inferred relationship | Some | 3 | |
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | stelkrampsvaccin | false | Inferred relationship | Some | 4 | |
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | difterivaccin | false | Inferred relationship | Some | 2 | |
| rekombinant hepatit B-ytantigen 10 mikrogram, difteritoxoid 30 IE, tetanustoxoid 40 IE, acellulär kikhosta 25 mikrogram, injektionsvätska, lösning, förfylld spruta 0,5 ml | Has active ingredient | rekombinant vaccin mot hepatit B-virus | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)
FHIR